Skip to search formSkip to main contentSkip to account menu

Trisequens

Known as: Trisekvens 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (5)

Contraceptives, OralDrug CombinationsEstradiolEstriol
Kliogestanalogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Monogenic diabetes, renal dysplasia and hypopituitarism: a patient with a HNF1A mutation.
A 38-year-old lady (III.1 in Figure 1) was referred to the nephrology services with an increase in her plasma creatinine from 108… 
2005
2005
[Effects of estro-progestagens on lipid and hormonal profiles in women with premature primary ovarian failure].
INTRODUCTION Premature primary ovarian failure (PPOF) is defined as cessation of menstruation before the age of 40. Women with… 
2003
2003
Differing effects of oral and transdermal hormone replacement therapy on cardiovascular risk factors in healthy postmenopausal women.
1999
1999
A randomised comparison of the effects of oral versus transdermal 17β‐oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels
Objective To investigate the effects of oral versus, transdermal 17β‐oestradiol, given in both cases with sequential addition of… 
1989
1989
Comparison of continuous and sequential oestrogen-progestogen treatment in women with climacteric symptoms.
1984
1984
Endometrial changes after long-term use of continuous oestrogen and cyclic progestogen.
1984
1984
Effect on lipoproteins of Trisequens, a combined hormone preparation.
1981
1981
Trisequens
Trisequens is a new product for oestrogen replacement therapy made by Novo and marketed here by Organon. It is described as a… 
1979
1979
Plasma concentrations of unconjugated and conjugated estrogens and gonadotrophins following application of various estrogen preparations after oophorectomy and in the menopause.
1979
1979
[Estradiol and estriol in the treatment of climacteric symptoms. A controlled trial].
4 preparations for treating menstrual disorders were tested in a double-blind study of 171 women. Trisekvens and Gynovin were… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)